Mereo BioPharma Group climbs 9% in regular trading

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Mereo BioPharma Group (MREO.US) climbed nearly 9% during regular trading to $0.3229.

The stock is up 12.35% over the past five sessions and down 22.51% year to date. It sits 61.45% above its 52-week low of US$0.2000.

The Nasdaq Composite is up 0.84% over the past five sessions and up 12.85% year to date.

The biotechnology industry index rose 1.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.